# American Institute of Mathematical Sciences

• Previous Article
Unbounded state-dependent sweeping processes with perturbations in uniformly convex and q-uniformly smooth Banach spaces
• NACO Home
• This Issue
• Next Article
Globalizer: A novel supercomputer software system for solving time-consuming global optimization problems
March  2018, 8(1): 63-80. doi: 10.3934/naco.2018004

## Mathematical model of Chimeric Anti-gene Receptor (CAR) T cell therapy with presence of cytokine

 1 Ferdowsi University of Mashhad, Mashhad, Iran 2 Interdisciplinary Centre for Scientific Computing (IWR) and BIOQUANT Ruprecht-Karls-Universitat, Heidelberg, Germany

* Corresponding author

Received  December 2016 Revised  January 2018 Published  March 2018

In this paper, we reconstruct a mathematical model of therapy by CAR T cells for acute lymphoblastic leukemia (ALL) With injection of modified T cells to body, then some signs such as fever, nausea and etc appear. These signs occur for the sake of cytokine release syndrome (CRS). This syndrome has a direct effect on result and satisfaction of therapy. So, the presence of cytokine will be played an important role in modelling process of therapy (CAR T cells). Therefore, the model will include the CAR T cells, B healthy and cancer cells, other circulating lymphocytes in blood, and cytokine. We analyse stability conditions of therapy Without any control, the dynamic model evidences sub-clinical or clinical decay, chronic destabilization, singularity immediately after a few hours and finally, it depends on the initial conditions. Hence, we try to show by which conditions, therapy will be effective. For this aim, we apply optimal control theory. Since the therapy of CAR T cells affects on both normal and cancer cell; so the optimization dose of CAR T cells will be played an important role and added to system as one controller $u_{1}$. On the other hand, in order to control of cytokine release syndrome which is a factor for occurrence of singularity, one other controller $u_{2}$ as tocilizumab, an immunosuppressant drug for cytokine release syndrome is added to system. At the end, we apply method of Pontryagin's maximum principle for optimal control theory and simulate the clinical results by Matlab (ode15s and ode45).

Citation: Reihaneh Mostolizadeh, Zahra Afsharnezhad, Anna Marciniak-Czochra. Mathematical model of Chimeric Anti-gene Receptor (CAR) T cell therapy with presence of cytokine. Numerical Algebra, Control & Optimization, 2018, 8 (1) : 63-80. doi: 10.3934/naco.2018004
##### References:

show all references

##### References:
Expression of CD19 and other B cell markers on B lineage cells
Graph of solutions $x(t), y(t), z(t), w(t), v(t)$
Graph of solutions $x(t), y(t), z(t), w(t), v(t)$ with a new initial condition
Graph of optimal solutions $x^{*}(t), y^{*}(t), z^{*}(t), w^{*}(t), v^{*}(t)$ for 1 month
Graph of optimal controls
 [1] Giuseppina Guatteri, Federica Masiero. Stochastic maximum principle for problems with delay with dependence on the past through general measures. Mathematical Control & Related Fields, 2020  doi: 10.3934/mcrf.2020048 [2] Fabio Camilli, Giulia Cavagnari, Raul De Maio, Benedetto Piccoli. Superposition principle and schemes for measure differential equations. Kinetic & Related Models, , () : -. doi: 10.3934/krm.2020050 [3] H. M. Srivastava, H. I. Abdel-Gawad, Khaled Mohammed Saad. Oscillatory states and patterns formation in a two-cell cubic autocatalytic reaction-diffusion model subjected to the Dirichlet conditions. Discrete & Continuous Dynamical Systems - S, 2020  doi: 10.3934/dcdss.2020433

Impact Factor: